Antibodies	O
to	O
PAI	O
-	O
1	O
alter	O
the	O
invasive	O
and	O
migratory	O
properties	O
of	O
human	O
tumour	B-Cell
cells	I-Cell
in	O
vitro	O
.	O

Recent	O
reports	O
suggest	O
that	O
elevated	O
levels	O
of	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
may	O
contribute	O
to	O
tumour	B-Cancer
progression	O
.	O

The	O
studies	O
reported	O
here	O
were	O
designed	O
to	O
help	O
elucidate	O
PAI	O
-	O
1	O
'	O
s	O
contribution	O
to	O
the	O
invasive	O
and	O
migratory	O
phenotype	O
.	O

Antibodies	O
to	O
PA	O
-	O
1	O
dose	O
-	O
dependently	O
,	O
and	O
significantly	O
,	O
inhibited	O
the	O
invasive	O
and	O
migratory	O
potential	O
of	O
human	O
HT1080	B-Cell
fibrosarcoma	I-Cell
cells	I-Cell
,	O
as	O
did	O
an	O
antibody	O
to	O
uPA	O
and	O
the	O
plasmin	O
inhibitor	O
aprotinin	O
.	O

Invasion	O
of	O
the	O
human	O
melanoma	B-Cell
cell	I-Cell
line	I-Cell
,	O
BLM	B-Cell
,	O
was	O
also	O
attenuated	O
by	O
the	O
anti	O
-	O
PAI	O
-	O
1	O
monoclonal	O
antibody	O
MAI	O
-	O
12	O
.	O

The	O
non	O
-	O
invasive	O
human	O
melanoma	B-Cell
cell	I-Cell
line	I-Cell
,	O
IF6	B-Cell
,	O
which	O
does	O
not	O
express	O
uPA	O
,	O
provided	O
further	O
confirmation	O
of	O
PAI	O
-	O
1	O
and	O
uPA	O
'	O
s	O
role	O
as	O
,	O
upon	O
transfection	O
with	O
uPA	O
,	O
this	O
cell	B-Cell
line	I-Cell
attained	O
an	O
invasive	O
phenotype	O
,	O
which	O
was	O
again	O
attenuated	O
by	O
MAI	O
-	O
12	O
.	O

Although	O
antibodies	O
to	O
PAI	O
-	O
1	O
did	O
not	O
affect	O
the	O
adhesion	O
of	O
HT1080	B-Cell
cells	I-Cell
to	O
vitronectin	O
,	O
the	O
antibody	O
to	O
uPA	O
reduced	O
their	O
attachment	O
.	O

Addition	O
of	O
exogenous	O
PAI	O
-	O
1	O
,	O
however	O
,	O
prevented	O
HT1080	B-Cell
cell	I-Cell
adhesion	O
(	O
IC50	O
180	O
nM	O
)	O
and	O
promoted	O
cell	B-Cell
detachment	O
from	O
vitronectin	O
.	O

Furthermore	O
melanoma	B-Cell
cells	I-Cell
transfected	O
with	O
a	O
uPA	O
variant	O
,	O
which	O
had	O
an	O
impaired	O
interaction	O
with	O
PAI	O
-	O
1	O
,	O
were	O
not	O
invasive	O
and	O
had	O
impaired	O
binding	O
to	O
vitronectin	O
.	O

These	O
data	O
highlight	O
the	O
importance	O
of	O
a	O
balanced	O
proteolysis	O
and	O
suggest	O
an	O
additional	O
role	O
for	O
PAI	O
-	O
1	O
distinct	O
from	O
its	O
role	O
in	O
proteolysis	O
.	O

These	O
data	O
also	O
suggest	O
that	O
uPA	O
and	O
PAI	O
-	O
1	O
may	O
co	O
-	O
operate	O
in	O
the	O
migratory	O
process	O
by	O
respectively	O
facilitating	O
the	O
attachment	O
to	O
,	O
and	O
subsequent	O
detachment	O
from	O
,	O
vitronectin	O
in	O
the	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
.	O

These	O
results	O
support	O
the	O
clinical	O
findings	O
and	O
indicate	O
that	O
modulation	O
of	O
PAI	O
-	O
1	O
activity	O
may	O
be	O
of	O
therapeutic	O
benefit	O
for	O
the	O
treatment	O
of	O
cancer	B-Cancer
.	O

